Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tiratricol Treatment of Children With Monocarboxylate Transporter 8 Deficiency: Triac Trial II

Trial Profile

Tiratricol Treatment of Children With Monocarboxylate Transporter 8 Deficiency: Triac Trial II

Status: Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 25 Mar 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tiratricol (Primary)
  • Indications Allan-Herndon-Dudley syndrome
  • Focus Registrational; Therapeutic Use
  • Acronyms Triac Trial II
  • Sponsors Rare Thyroid Therapeutics
  • Most Recent Events

    • 16 Mar 2023 This trial has been completed in France, according to European Clinical Trials Database record.
    • 22 Feb 2023 According to Egetis media release, the recruitment target has been achieved in the 2022, where 22 patients have been included in the study.
    • 14 Nov 2022 According to an Egetis Therapeutics media release, results from the study are expected in mid-2024 and are planned to be submitted to regulatory authorities after market approvals have been obtained.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top